find the latest legal job
Corporate Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Highly-respected, innovative and entrepreneurial Not-for-Profit · Competency based Board
View details
Chief Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Dynamic, high growth organisation · ASX listed market leader
View details
In-house Projects Lawyer | Renewables / Solar | 2-5 Years PQE
Category: Generalists - In House | Location: All Australia
· Help design the future · NASDAQ Listed
View details
Corporate Lawyer
Category: Generalists - In House | Location: Melbourne CBD & Inner Suburbs Melbourne VIC
· 12 months fixed term opportunity
View details
Property lawyer - Melbourne
Category: Property Law | Location: Melbourne CBD & Inner Suburbs Melbourne VIC
· Impressive client list, national firm · Well-led and high-performing team
View details
Pharmaceutical business sold for $930m

Pharmaceutical business sold for $930m

Sold signage

A global firm has advised Valeant on the sale of its pharmaceutical business which operates in more than 15 countries.

Firms: Baker McKenzie (Valeant); Undisclosed (iNova Pharmaceuticals)

Deal: Valeant Pharmaceuticals International, Inc. (Valeant) has been advised on the sale of its iNova Pharmaceuticals (iNova) business to Pacific Equity Partners and The Carlyle Group.

Value: $930 million

Area: M&A

Key players: The legal team advising Valeant was led by Baker McKenzie partner Chris Saxon, with assistance from partners David Holland, Adrian Lawrence and Jonathan Flintoft, senior associates Lucas Tyszkiewicz, Julie Cox and Sally Head, and associates Lydia Turman and Amalesh Sukumar.

Deal significance: This transaction saw Valeant enter into an agreement to sell its iNova business to a company jointly owned by funds advised and managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash, according to a statement from Baker McKenzie.

iNova is described as a diversified portfolio of prescription and over-the-counter products in several areas, such as weight management, pain management, cardiology and cough and cold.

The business operates in more than 15 countries around the world.

The statement from Baker McKenzie said: “Valeant will use proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the second half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals”.

Baker McKenzie lead partner on the transaction, Chris Saxon added: “We were delighted to act for our long-standing client, Valeant, and to assist them in implementing their strategic plans to simplify the company’s business and strengthen its balance sheet”.

The firm noted that Goldman, Sachs & Co served as financial advisor to Valeant in this transaction.

 

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Pharmaceutical business sold for $930m
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
Warning
Aug 23 2017
NT Law Society sounds alarm on mandatory sentencing
The Law Society Northern Territory has issued a warning over mandatory sentencing, saying it hasn’...
Unite
Aug 22 2017
Professionals unite in support of marriage equality
The presidents of representative bodies for solicitors, barristers and doctors in NSW have come toge...
Aug 21 2017
Is your firm on the right track for gig economy gains?
Promoted by The way we do business, where we work, how we engage with workers, even how we take a...
APPOINTMENTS
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
opinion
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
Help
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...